Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-006272

See Remarks sold 15,093 shares at an average $14.84 ($223,965)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schwartz Jonathan David See Remarks 2024-05-17 Sale −2,754 $23.35 $64,306 169,659 D: show line 1 in the form
Schwartz Jonathan David See Remarks 2024-08-16 Sale −2,710 $18.50 $50,135 166,949 D: show line 2 in the form
Schwartz Jonathan David See Remarks 2024-11-21 Sale −3,097 $13.05 $40,416 163,852 D: show line 3 in the form
Schwartz Jonathan David See Remarks 2025-02-25 Sale −6,532 $10.58 $69,109 237,638 D: show line 4 in the form
Open-market sales · 15,093 sh · avg $14.84 · $223,965
Loading xslF345X05/form4.xml…